Oral bioavailability enhancement of doxazosin mesylate: Nanosuspension versus self-nanoemulsifying drug delivery systems. ADMET and DMPK, [S. l.], v. 12, n. 1, p. 167–176, 2023. DOI: 10.5599/admet.2022. Disponível em: https://pub.iapchem.org/ojs/index.php/admet/article/view/2022. Acesso em: 18 nov. 2025.